OCT 23, 2019 10:37 AM PDT

Why the Michael J. Fox Foundation Advocates for Cannabis Research

WRITTEN BY: Julia Travers

The Michael J. Fox Foundation for Parkinson’s Research (MJFF), which was established by and is named after the actor who has the disease, continues to advocate for cannabis research. As reported by Marijuana Moment, the group is currently pushing Congress to pass three bills relating to cannabis research and medical marijuana; the Medical Cannabis Research Act, VA Medicinal Cannabis Research Act and Expanding Cannabis Research and Information Act.

“Our role on the public policy team is to work with Congress and the administration to ensure there is access and funding for research and care initiatives that can benefit people living with Parkinson’s and, right now, that includes access to medical cannabis for research,” Ted Thompson, the foundation’s senior vice president of public policy, said. According to the MJFF site, the public policy team is currently tracking these bills and aims to inform members of Congress and their staff as to why the bills matter to the Parkinson’s community.

The bills MJFF supports have various goals. The Medical Cannabis Research Act would require the Justice Department to approve more research-grade cannabis manufacturers, provide protection to research organizations that study marijuana, and authorize the Department of Veterans Affairs (VA) to tell patients about the option to participate in federal cannabis studies.

Under the VA Medicinal Cannabis Research Act, the VA would investigate marijuana’s therapeutic potential in regard to treating conditions that often affect veterans, like PTSD or chronic pain.

The Expanding Cannabis Research and Information Act would reschedule marijuana from a Schedule I to Schedule III within the U.S. Controlled Substances Act (CSA), and alter current regulatory requirements in order to permit institutions of higher learning to study cannabis.

Earlier, in 2018 and 2019, MJFF also submitted comments to the Food and Drug Administration in favor of rescheduling.

“Right now, more research is needed to better understand if cannabis (including marijuana and CBD products) could treat Parkinson’s disease,” the foundation site states.

Article sources: Marijuana Moment, Michael J. Fox Foundation

 
About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
JUL 08, 2020
Health & Medicine
The Myths About CBD and Coronavirus
JUL 08, 2020
The Myths About CBD and Coronavirus
Research collected over the last 20 years suggests that cannabidiol – the primary cannabinoid in CBD oil – h ...
JUL 22, 2020
Immunology
CBD May Reduce Cytokine Storm & Lung Inflammation in COVID-19
JUL 22, 2020
CBD May Reduce Cytokine Storm & Lung Inflammation in COVID-19
Initial studies of cannabidiol’s impact of classic symptoms of lung damage in severe cases of COVID-19 provide a p ...
JUL 23, 2020
Cannabis Sciences
Lab Tests Show Levels of THC Can Rise in CBD Oil During Storage
JUL 23, 2020
Lab Tests Show Levels of THC Can Rise in CBD Oil During Storage
To be federally legal in all states CBD (cannabidiol) oil must contain less than 0.3 percent of the psychoactive ingredi ...
AUG 11, 2020
Cannabis Sciences
High THC Cannabis Linked to Anxiety
AUG 11, 2020
High THC Cannabis Linked to Anxiety
Researchers have found that people who use strains of cannabis high in tetrahydrocannabinol (THC), the psychoactive comp ...
AUG 14, 2020
Health & Medicine
Does Legalization of Cannabis Mean Users Actually Use Legal Sources?
AUG 14, 2020
Does Legalization of Cannabis Mean Users Actually Use Legal Sources?
Recent research from states that have legalized recreational cannabis, looked at whether users find the drug  is mo ...
SEP 09, 2020
Health & Medicine
Cannabis Legalization Not Linked With Pedestrian Deaths
SEP 09, 2020
Cannabis Legalization Not Linked With Pedestrian Deaths
Changes in cannabis legalization status haven’t caused an uptick in pedestrians being killed by cars, a study has ...
Loading Comments...